Find A Clinical Trial

Disease Type: Prostate

Trial ID RN5609C00
Sponsor ID PRO-MERIT

“First-in-human, dose titration and expansion trial to evaluate safety, immunogenicity and preliminary efficacy of W_pro1 (BNT112) monotherapy and in combination with cemiplimab in patients with prostate cancer”

1 Location
Trial ID CP-MGC018-03
Sponsor ID Tamarack

“A Phase 2/3, Randomized, Open-label, Study of MGC018 Versus Androgen Receptor Axis-targeted Therapy (Abiraterone or Enzalutamide) in Participants with Metastatic Castration-resistant Prostate Cancer”

3 Locations
Trial ID ARV-766-mCRPC-101
Sponsor ID Arvinas

“A Phase 1/2 Open-Label, Dose-Escalation and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-766 in Patients with Metastatic Castration-Resistant Prostate Cancer”

Principal Investigator
Mitul Gandhi, MD
3 Locations
Trial ID TT-10-101
Sponsor ID TT-10-101

Phase I/II First-in-Human Study of TT-10 as a Single Agent in Subjects With Advanced Selected Solid Tumors

Trial ID NUV868
Sponsor ID NUV-868-01

Phase 1/2 Safety and Efficacy Study of NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Trial ID IDE161-001
Sponsor ID IDE161-001

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Trial ID NUV-422-04
Sponsor ID Nuvation Bio

A Phase 1b/2 Safety and Efficacy Study of NUV-422 in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

1 Location